ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – INSD, MZKR
11. Februar 2022 15:18 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC: INSD,...